Bacitracin Topical


Article Author:
Rosalee Nguyen


Article Editor:
Yan Sun


Editors In Chief:
Stephen Leslie
Karim Hamawy


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
5/16/2019 12:00:40 PM

Indications

Bacitracin is a topical antibiotic ointment widely used by both medical professionals and the general public to treat minor skin injuries including cuts, scrapes, and burns.

Bacitracin was discovered in 1945 from a leg injury of a seven-year-old American girl named Margaret Tracey. The collected debris from her wound grew isolates of several related cyclic polypeptides produced by a member of the Bacillus subtilis group. This discovery gave rise to the unique name, bacitracin.[1] 

The United States Food and Drug Administration (FDA) approved the use of bacitracin in 1948 for the short-term prevention and treatment of both acute and chronic localized skin infections. Less frequently, bacitracin can also be given as a parental medication via intramuscular (IM) injection for the systemic treatment of infantile streptococcal pneumonia and empyema. To date, there are no record of any non-FDA approved uses of topical bacitracin.

Bacitracin can be used as a single agent ointment or in combination as a triple therapy ointment, with neomycin and polymyxin B. The latter can be found over the counter (OTC) at local pharmacies.[2] 

Mechanism of Action

Bacitracin is a mixture of several closely related cyclic polypeptide antibiotics that has both bacteriostatic and bactericidal properties depending on the concentration of the drug and the susceptibility of the microorganism. 

Many gram-positive bacteria including Staphylococci, Streptococci, Corynebacterium, Clostridium, and Actinomyces are susceptible to bacitracin. Some gram-negative organisms, such as Gonococci and Meningococci also exhibit susceptibility; however, most gram-negative organisms are resistant.[3]

Bacitracin readily absorbs through denuded, burned, or granulated skin and works to prevent the transfer of mucopeptides into the cell wall of various microorganisms. This subsequently inhibits bacterial cell wall synthesis and ultimately, bacterial replication. Bacitracin also acts as an inhibitor of proteases and other enzymes involved in altering bacterial cell membrane function.[4]

Administration

Bacitracin is available in four different routes of administration:  topical, ophthalmic, parenteral via IM injection, and oral. 

Its most common use a topical agent that is administered directly onto the wound or infected area. It can also be administered as a topical ophthalmic ointment to treat superficial ocular infections involving the conjunctiva and cornea.[5] 

Before topical application, the skin should be cleansed gently with mild soap and water. Enough ointment should then be applied to cover the affected area(s), and a sterile dressing can be used to cover the wound. This helps to assist in wound healing and prevent further contamination of the wound site. 

Adverse Effects

When used topically as a single agent ointment or part of a triple therapy ointment, Bacitracin, and its components may cause allergic contact dermatitis which could lead to an anaphylactoid reaction or anaphylaxis.[6]

Common and mild side effects of the topical use of Bacitracin include[2][7]

  • Fever
  • Hives
  • itching
  • Swelling of lips and face
  • Difficulty breathing
  • Nausea
  • Vomiting

Pregnancy[8]

  • Bacitracin is pregnancy risk category C.
  • No large studies have been conducted with the use of topical bacitracin during pregnancy or lactation.
  • To date, there is no evidence to suggest that there is an increased risk of adverse fetal development with the use of topical Bacitracin. 

Breast-Feeding[9]

  • Topical and ophthalmic forms of bacitracin typically result in minimal absorption through the skin and are considered a low risk to the feeding infant.
  • Only water-soluble creams or gel products should be applied to the breast tissue to prevent infant exposure to mineral paraffin from licking.

Contraindications

Topical bacitracin is contraindicated in anyone with hypersensitivity to bacitracin and/or any of its components. Patients with known hypersensitivity to neomycin may also be sensitive to bacitracin.

Bacitracin application on an infection or wound that is caused by a viral or fungal infection may increase the risk for the development of drug-resistant bacteria.  

Topical bacitracin use is recommended only for minor skin injuries and should not be used over larger areas of the body.

A physician consultation is recommended before using topical bacitracin for serious injuries such as burns, deep wounds, puncture wounds, or animal bites.[10][11]

Monitoring

Secondary infections may develop; therefore, topical bacitracin should not be used for more than seven days unless directed by a physician. The area of application should undergo monitoring for improvement. Bacitracin use should be stopped immediately if symptoms worsen and a physician contacted regarding further management.

Allergy patch testing may be warranted if an adverse reaction occurs after use of bacitracin as a single agent ointment or part of a triple therapy ointment. There have been multiple reports of anaphylactoid reactions and anaphylaxis due to bacitracin use.[6][12][13]

Toxicity

There is no mention of toxicity with the topical use of bacitracin as a single agent ointment or part of a triple therapy ointment.

However, the IM route has been shown to cause nephrotoxicity and renal failure due to tubular and glomerular necrosis. Consequently, careful monitoring is in order with the IM use of Bacitracin. Renal function should be determined before, during, and after IM administration. Patients' daily optimal fluid intake and urinary output should be followed closely to avoid kidney injury. 

Concurrent use of streptomycin, kanamycin, polymyxin E, and neomycin should be avoided as these drugs are also known to be nephrotoxic.[14][15]

Enhancing Healthcare Team Outcomes

Topical bacitracin has been easily accessible and considered a safe OTC topical antibiotic for the past seven decades. Despite its effectiveness, increases in use and adverse effects led to it earning, in 2003, the undesirable designation “contact allergen of the year” by the American Contact Dermatitis Society. In 2005-2006, it was also ranked the sixth most prevalent allergen in patch tests.[2][16][17][18]

As a result, all healthcare providers should be aware of the potential risks of an anaphylactoid reaction or anaphylaxis secondary to bacitracin use. Anyone with a confirmed contact dermatitis should avoid products containing bacitracin. Providers should encourage their patients to read the labels for bacitracin in ointments, creams, and other wound care products.

Providers should make a habit of inquiring about bacitracin use when encountering a patient with a possible contact allergy or unremitting dermatitis or non-healing wound as bacitracin allergy may present as cellulitis or a simple wound infection. One clinical clue to decipher an allergic reaction from an infectious process is the presence of itching instead of worsening pain, respectively. (Level III)

Bacitracin should be used cautiously in patients with pre-existing renal impairment or renal failure. To ensure patient safety, physicians, nurses and other medical staff should work as a team to monitor patients' intake, urinary output, and renal function. Due to the significant risk of nephrotoxicity, pharmacists should provide alternative medication options when available. 

Bacitracin is also present in some veterinary products, and pet owners should also be highly cautious when applying products.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Bacitracin Topical - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following medications is most effective in topically treating Streptococcal skin infections?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the mechanism of action of bacitracin?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which topical medication is a treatment choice for a patient who presents with a superficial skin abrasion sustained after a fall?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following medications is applied topically to treat gram-positive skin infections?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Why is bacitracin typically not given parenterally despite it being available in injectable form?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Bacitracin Topical - References

References

WRONG NM,SMITH RC,HUDSON AL,HAIR HC, The treatment of pyogenic skin infections with bacitracin ointment. Treatment services bulletin. Canada. Department of Veterans' Affairs. 1951 Jun     [PubMed]
Schalock PC,Zug KA, Bacitracin. Cutis. 2005 Aug     [PubMed]
Stone KJ,Strominger JL, Mechanism of action of bacitracin: complexation with metal ion and C 55 -isoprenyl pyrophosphate. Proceedings of the National Academy of Sciences of the United States of America. 1971 Dec     [PubMed]
Johnson BA,Anker H,Meleney FL, BACITRACIN: A NEW ANTIBIOTIC PRODUCED BY A MEMBER OF THE B. SUBTILIS GROUP. Science (New York, N.Y.). 1945 Oct 12     [PubMed]
Gigliotti F,Hendley JO,Morgan J,Michaels R,Dickens M,Lohr J, Efficacy of topical antibiotic therapy in acute conjunctivitis in children. The Journal of pediatrics. 1984 Apr     [PubMed]
Cronin H,Mowad C, Anaphylactic reaction to bacitracin ointment. Cutis. 2009 Mar     [PubMed]
Sheth VM,Weitzul S, Postoperative topical antimicrobial use. Dermatitis : contact, atopic, occupational, drug. 2008 Jul-Aug     [PubMed]
Leachman SA,Reed BR, The use of dermatologic drugs in pregnancy and lactation. Dermatologic clinics. 2006 Apr     [PubMed]
Murase JE,Heller MM,Butler DC, Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. Journal of the American Academy of Dermatology. 2014 Mar     [PubMed]
Jones RN,Li Q,Kohut B,Biedenbach DJ,Bell J,Turnidge JD, Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia. Diagnostic microbiology and infectious disease. 2006 Jan     [PubMed]
Bonomo RA,Van Zile PS,Li Q,Shermock KM,McCormick WG,Kohut B, Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective. Expert review of anti-infective therapy. 2007 Oct     [PubMed]
Katz BE,Fisher AA, Bacitracin: a unique topical antibiotic sensitizer. Journal of the American Academy of Dermatology. 1987 Dec     [PubMed]
Saryan JA,Dammin TC,Bouras AE, Anaphylaxis to topical bacitracin zinc ointment. The American journal of emergency medicine. 1998 Sep     [PubMed]
Levin HS,Kagan BM, Antimicrobial agents: pediatric dosage, routes of administration and preparation procedures for parenteral therapy. Pediatric clinics of North America. 1968 Feb     [PubMed]
KOCH R,DONNELL G, Staphylococcic infections in children. California medicine. 1957 Nov     [PubMed]
Sood A,Taylor JS, Bacitracin: allergen of the year. American journal of contact dermatitis : official journal of the American Contact Dermatitis Society. 2003 Mar     [PubMed]
Spring S,Pratt M,Chaplin A, Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic. Dermatitis : contact, atopic, occupational, drug. 2012 Sep-Oct     [PubMed]
Zug KA,Warshaw EM,Fowler JF Jr,Maibach HI,Belsito DL,Pratt MD,Sasseville D,Storrs FJ,Taylor JS,Mathias CG,Deleo VA,Rietschel RL,Marks J, Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis : contact, atopic, occupational, drug. 2009 May-Jun     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.